China Traditional Chinese Medicine Holdings Co. Limited (HKG:0570)
2.400
-0.010 (-0.41%)
Oct 24, 2025, 2:45 PM HKT
HKG:0570 Revenue
China Traditional Chinese Medicine Holdings Co. had revenue of 7.46B CNY in the half year ending June 30, 2025, a decrease of -19.77%. This brings the company's revenue in the last twelve months to 15.59B, down -9.40% year-over-year. In the year 2024, China Traditional Chinese Medicine Holdings Co. had annual revenue of 16.51B, down -8.90%.
Revenue (ttm)
15.59B CNY
Revenue Growth
-9.40%
P/S Ratio
0.70
Revenue / Employee
930.44K CNY
Employees
16,753
Market Cap
12.04B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 16.51B | -1.61B | -8.90% |
| Dec 31, 2023 | 18.12B | 3.82B | 26.69% |
| Dec 31, 2022 | 14.30B | -4.75B | -24.92% |
| Dec 31, 2021 | 19.05B | 4.25B | 28.68% |
| Dec 31, 2020 | 14.81B | 485.22M | 3.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JD Health International | 71.34B |
| BeOne Medicines AG | 35.81B |
| Sino Biopharmaceutical | 33.49B |
| Alibaba Health Information Technology | 32.81B |
| CSPC Pharmaceutical Group | 28.49B |
| WuXi Biologics | 21.98B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| Innovent Biologics | 12.52B |